Company intelligence / Profile preview

Deep Science Ventures

London, England, United Kingdomdeepscienceventures.com ↗

Ownership: Private
Employees: ~40
Development stage: Other

Overview

As a venture creator/incubator/fund, DSV has launched 50+ science-driven startups across pharma/biotech and other sectors since 2016. Its model focuses on building new ventures from the ground up by combining founder-type scientists with deep technical expertise to address major global challenges. In pharmaceuticals alone, its ventures have 24 drugs under development as of mid 2024.

Therapeutic areas: Other
Modalities: Monoclonal antibodySmall moleculeBiologic
Industry: Investors

Partnerships

UniversitiesCorporates

Beyond the preview

Go deeper on Deep Science Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deep Science Ventures.

Explore the full profile